You just read:

MaxCyte, Inc. to Present Pre-Clinical Data for Targeted Gene-Correction in a Rare Disease at Keystone Symposia on Precision Genome Engineering

News provided by

MaxCyte, Inc.

Jan 04, 2017, 09:15 ET